Robert Shapiro, AHS 2021: Impact of COVID-19 on Patients with Migraine
Access all of the content
touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine.
The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency of COVID-19 Symptoms, but Lower COVID-19-Associated Health Care Resource Utilization Rates’ was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 June 2021.
Questions:
- What has been the impact of the COVID-19 pandemic on patients with migraine? (0:16)
- How can headache specialists best respond to the challenges posed by the pandemic? (3:47)
Disclosures: Robert Shapiro has provided research consultation for Eli Lilly and Lundbeck, within the past 12 months.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of AHS Virtual Annual Scientific Meeting 2021.
